Neutropenia Information Center
A low white blood cell count or “neutropenia” is a condition characterized by abnormally low levels of neutrophils in the circulating blood. Neutrophils are a specific kind of white blood cell that help prevent and fight infections. The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy. Chemotherapy-induced neutropenia increases a patient’s risk of infection and disrupts cancer treatment. Fortunately, neutropenia can be prevented through the use of white blood cell growth factors. The prevention of neutropenia allows patients to receive their scheduled treatment and reduces the risk of infection and hospitalization.
Twice daily naproxen can relieve the incidence and severity of Neulasta-induced bone pain. Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma Neulasta® Deemed Cost-effective for Prevention of Febrile Neutropenia in Breast Cancer Patients
If you were to ask the average person—even the most health conscious of your friends—what their neutrophil count is... Successful Treatment Means Staying on Schedule